Placing the Cell and Gene Therapy Catapult at the forefront of translational research: an interview with Jonathan Appleby
In this interview, Jonathan Appleby discusses his appointment as the new Chief Scientific Officer of the Cell and Gene Therapy Catapult.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.